The emerging field of pancreatic tissue engineering: A systematic review and evidence map of scaffold materials and scaffolding techniques for insulin-secreting cells

GA Salg, NA Giese, M Schenk… - Journal of tissue …, 2019 - journals.sagepub.com
A bioartificial endocrine pancreas is proposed as a future alternative to current treatment
options. Patients with insulin-secretion deficiency might benefit. This is the first systematic …

No time to die—how islets meet their demise in transplantation

A Kale, NM Rogers - Cells, 2023 - mdpi.com
Islet transplantation represents an effective treatment for patients with type 1 diabetes
mellitus (T1DM) and severe hypoglycaemia unawareness, capable of circumventing …

The preclinical and clinical progress of cell sheet engineering in regenerative medicine

D Hu, X Li, J Li, P Tong, Z Li, G Lin, Y Sun… - Stem Cell Research & …, 2023 - Springer
Cell therapy is an accessible method for curing damaged organs or tissues. Yet, this
approach is limited by the delivery efficiency of cell suspension injection. Over recent years …

Therapeutic strategies for modulating the extracellular matrix to improve pancreatic islet function and survival after transplantation

AM Smink, P de Vos - Current diabetes reports, 2018 - Springer
Abstract Purposes of Review Extracellular matrix (ECM) components modulate the
interaction between pancreatic islet cells. During the islet isolation prior to transplantation as …

Recent advances in the design of implantable insulin secreting heterocellular islet organoids

MB Akolpoglu, Y Inceoglu, U Bozuyuk, AR Sousa… - Biomaterials, 2021 - Elsevier
Islet transplantation has proved one of the most remarkable transmissions from an
experimental curiosity into a routine clinical application for the treatment of type I diabetes …

Engineering β cell replacement therapies for type 1 diabetes: biomaterial advances and considerations for macroscale constructs

MJ Quizon, AJ García - Annual Review of Pathology …, 2022 - annualreviews.org
While significant progress has been made in treatments for type 1 diabetes (T1D) based on
exogenous insulin, transplantation of insulin-producing cells (islets or stem cell–derived β …

Magnetically Actuated SiCN‐Based Ceramic Microrobot for Guided Cell Delivery

KW Gyak, S Jeon, L Ha, S Kim, J Kim… - Advanced …, 2019 - Wiley Online Library
A silicon carbonitride (SICN) ceramic microrobot, biocompatible and magnetically activable,
is developed for the delivery of viable cells to defective tissue by sequential steps of …

Fibroblasts accelerate islet revascularization and improve long-term graft survival in a mouse model of subcutaneous islet transplantation

M Perez-Basterrechea, MM Esteban, M Alvarez-Viejo… - PLoS …, 2017 - journals.plos.org
Pancreatic islet transplantation has been considered for many years a promising therapy for
beta-cell replacement in patients with type-1 diabetes despite that long-term clinical results …

An engineered cell sheet composed of human islets and human fibroblast, bone marrow–derived mesenchymal stem cells, or adipose–derived mesenchymal stem …

H Imamura, T Adachi, T Kin, S Ono, Y Sakai, T Adachi… - Islets, 2018 - Taylor & Francis
Background: We previously reported the utility of engineered cell sheets composed of
human islets and supporting cells in vitro and in vivo. It is unclear which type of supporting …

Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review

NE Lemos, LA Brondani, C Dieter, J Rheinheimer… - Islets, 2017 - Taylor & Francis
Pancreatic islet transplantation is an established treatment to restore insulin independence
in type 1 diabetic patients. Its success rates have increased lately based on improvements in …